Evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the USA: A simulation modelling study

BMJ Open

Volumn 6, Issue 2, 2016, Pages

  Tramontano, Angela C ^a   Sheehan, Deirdre F ^a   McMahon, Pamela M ^a,b   Dowling, Emily C ^a   Holford, Theodore R ^c   Ryczak, Karen ^d   Lesko, Samuel M ^d   Levy, David T ^e   Kong, Chung Yin ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY   (United States)

^d Northeast Regional Cancer Institute   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL EVALUATION; COHORT ANALYSIS; COMPUTER SIMULATION; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREVALENCE; SMOKING CESSATION; SMOKING CESSATION PROGRAM; UNITED STATES; INCIDENCE; LUNG NEOPLASMS; PENNSYLVANIA; PROGRAM EVALUATION; SENSITIVITY AND SPECIFICITY; SMOKING; STATISTICS AND NUMERICAL DATA;

COMPUTER SIMULATION; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PENNSYLVANIA; PROGRAM EVALUATION; SENSITIVITY AND SPECIFICITY; SMOKING; SMOKING CESSATION;

EID: 84960329111     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010227     Document Type: Article

References (32)

1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. National Cancer Institute. National Lung Screening Trial Results 2010 (4 November 2010). http://www.cancer.gov/newscenter/pressreleases/NLSTresultsRelease
3. Aberle DR, Adams AM, Berg CD, National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
4. Moyer VA. Screening for lung cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8.
5. Centers for Medicare & Medicaid Services. Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N) 2015 (5 February 2015 and 29 July 2015). http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274&NcaName=Screening+for +Lung+Cancer+with+Low+Dose+Computed+Tomography+ (LDCT) &TimeFrame=7&DocType=All&bc=AQAAIAAAAgAAAA%3d%3d&
6. Chahine T, Subramanian SV, Levy JI. Sociodemographic and geographic variability in smoking in the U. S.: a multilevel analysis of the 2006-2007 Current Population Survey, Tobacco Use Supplement. Soc Sci Med 2011;73:752-8.
7. Smieliauskas F, MacMahon H, Salgia R, et al. Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening. J Med Screen 2014;21:207-15.
8. Jarvandi S, Yan Y, Schootman M. Income disparity and risk of death: the importance of health behaviors and other mediating factors. PLoS ONE 2012;7:e49929.
9. Koh HK, Nowinski JM, Piotrowski JJ. A 2020 vision for educating the next generation of public health leaders. Am J Prev Med 2011;40:199-202.
10. Garrett BE, Dube SR, Winder C, et al. Cigarette smoking-United States, 2006-2008 and 2009-2010. MMWR Surveill Summ 2013;62(Suppl 3):81-4.
11. Lesko SM. Cancer in Northeastern Pennsylvania: Incidence, Mortality and Survival for Common Cancers. http://www.cancernepa.org: Northeast Regional Cancer Institute, 2011.
12. Pennsylvania Department of Public Health. EpiQMS (19 August 2015). https://apps.health.pa.gov/EpiQMS/asp/SelectParams-BRFSS-Tbl-Region.asp
13. McMahon PM, Kong CY, Weinstein MC, et al. Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer 2008;113:3440-9.
14. McMahon PM, Kong CY, Johnson BE, et al. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology 2008;248:278-87.
15. McMahon PM, Kong CY, Johnson BE, et al. Chapter 9: the MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal 2012;32(Suppl 1):S117-24.
16. Moolgavkar SH, Holford TR, Levy DT, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst 2012;104:541-8.
17. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-8.
18. Meza R, Ten Haaf K, Kong CY, et al. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. Cancer 2014;120:1713-24.
19. NRC (National Research Council). Health risks from exposure to low levels of ionizing radiation. BEIR VII phase 2. Washington DC: National Academy Press, 2005.
20. Egawa H, Furukawa K, Preston D, et al. Radiation and smoking effects on lung cancer incidence by histological types among atomic bomb survivors. Radiat Res 2012;178:191-201.
21. Centers for Disease Control and Prevention. Behavioral risk factor surveillance system survey data. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2002-2006.
22. Ashmore JH, Lesko SM, Miller PE, et al. Association of dietary and supplemental iron and colorectal cancer in a population-based study. Eur J Cancer Prev 2013;22:506-11.
23. Centers for Disease Control and Prevention. Behavioral risk factor surveillance system survey data. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2010.
24. Holford TR, Levy DT, McKay LA, et al. Patterns of birth cohort-specific smoking histories, 1965-2009. Am J Prev Med 2014;46:e31-7.
25. Levy DT, Graham AL, Mabry PL, et al. Modeling the impact of smoking-cessation treatment policies on quit rates. Am J Prev Med 2010;38(3 Suppl):S364-72.
26. Schauffler HH, McMenamin S, Olson K, et al. Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial. Tob Control 2001;10:175-80.
27. Levy DT, Friend K. A simulation model of policies directed at treating tobacco use and dependence. Med Decis Making 2002;22:6-17.
28. Clarke TC, Soler-Vila H, Fleming LE, et al. Trends in adherence to recommended cancer screening: the US population and working cancer survivors. Front Oncol 2012;2:190.
29. Wang Y, Midthun DE, Wampfler JA, et al. Trends in the proportion of patients with lung cancer meeting screening criteria. JAMA 2015;313:853-5.
30. Aberle DR, Adams AM, Berg CD, et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010;102:1771-9.
31. Levy DT, Mabry PL, Graham AL, et al. Reaching Healthy People 2010 by 2013: a SimSmoke simulation. Am J Prev Med 2010;38(3 Suppl):S373-81.
32. Abrams DB, Graham AL, Levy DT, et al. Boosting population quits through evidence-based cessation treatment and policy. Am J Prev Med 2010;38(3 Suppl):S351-63.